Y.S.P.). Travin D.Y. et al. Manuscript P a g e | 2 of 32 ABSTRACT Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a rapidly expanding and largely untapped class of natural products with various biological activities. Linear azol(in)e-containing peptides (LAPs) comprise a subclass of RiPPs that display an outstanding diversity of mechanisms of action while sharing common structural features. Here, we report the discovery of a new LAP biosynthetic gene cluster in the genome of Rhizobium sp.
INTRODUCTION
Since the discovery of the first antibiotics, natural products of bacterial and fungal origin serve as the predominant source of new compounds with various in-high-demand functional activities in the fight against ever-growing antibiotic resistance and cancer 1, 2 . While traditional activity-based screens often lead to the rediscovery of already known compounds, the ever-increasing genomic data make genome-mining based strategies viable alternatives in the search for new bioactive compounds. Ribosomally synthesized and post-translationally modified peptides (RiPPs) comprise a diverse class of natural products that are well suited for genome-mining approaches as their biosynthetic gene clusters (BGCs) contain multiple signature genes coding for enzymes performing posttranslational modifications and the peptide precursor genes, allowing to significantly improve the quality of bioinformatics predictions 3 .
Linear azol(in)e-containing peptides (LAPs) form a subfamily of RiPPs sharing thiazol(in)e and (methyl)oxazol(in)e heterocycles, which result from cyclization of Cys and Ser (Thr) side chains during the posttranslational modification of the precursor peptide 4 . In addition to the precursor peptide-coding gene (gene A) LAP BGCs typically include genes for an YcaO-domain containing cyclodehydratase (gene D), its partner protein (gene C or gene F), FMN-dependent dehydrogenase (gene B), which oxidizes azolines to azoles, and the efflux pump 5 . Although less than two dozens of LAPs can be considered as well-characterized, they demonstrate antibacterial activity through several completely different mechanisms. For example, microcin B17 is a DNAgyrase poison 6 , plantazolicin targets the membrane 7 , and klebsazolicin inhibits the ribosome 8 .
This diversity of modes of action, unprecedented for peptides sharing common chemical features, makes LAPs a group of special interest for the search of new antibacterials.
Here, we report the discovery of a new LAP BGC in the genome of Rhizobium sp. Pop5, and characterization of its product, phazolicin (PHZ)a novel linear thiazole/oxazole-modified peptide, which targets the bacterial ribosome. The producing strain, a symbiotic nitrogen-fixing bacterium was isolated in a tropical forest in Los Tuxtlas (Mexico) from the root nodules of wild beans (Phaseolus vulgaris, hence "phazolicin"). Although the studies of natural products with antibacterial properties produced by rhizobia date back to the 1960s 9 , the number of wellcharacterized compounds is still very small with trifolitoxin produced by R. leguminosarum bv.
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P a g e | 4 of 32 trifolii T24 being the only rhizobial thiazole/oxazole-containing RiPP described to date 10 . Being active against a variety of bacteria from Rhizobiales including several phytopathogens such as Agrobacterium tumifaciens and A. rhizogenes, phazolicin is not only interesting because of its idiosyncratic mode of interaction with the ribosome, but also as a potential agent for biocontrol in agriculture.
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RESULTS

Identification of a new LAP biosynthetic gene cluster.
Klebsazolicin (KLB) from Klebsiella pneumoniae is a recently characterized LAP, which inhibits prokaryotic translation through the obstruction of the ribosome exit tunnel 8 . The BGC of this RiPP (klpACBDE) contains genes encoding the precursor peptide (klpA), the three enzymes involved in the formation of azole cycles (klpC, klpB, and klpD) as well as a transmembrane pump (klpE) exporting the modified peptide. We used the amino acid sequences of KlpB and KlpD proteins as queries to search the NCBI non-redundant protein database using the PSI-BLASTP algorithm 11 followed by manual analysis of the genomic environment of the identified gene orthologues. Along with several previously described clusters of KLB homologs 8 a distinct BGC phzEACBD was found in the genome of Rhizobium sp. Pop5. Two other related BGCs were found in the genomes of Rhizobium sp. PDO1-076 and Phyllobacterium myrsinacearum DSM 5893, also belonging to the order Rhizobiales. The alignment of amino acid sequences of the predicted core parts of precursor peptides revealed a similar pattern of Cys/Ser/Thr residues, which potentially could be cyclized in the mature LAP product (Figure 1B, red) . The putative
PhzA precursor peptide has an amino acid sequence significantly different from that of the KLB precursor KlpA (Figure 1A) . As is the case with KlpA, the C-terminal part of the predicted PhzA precursor peptide is enriched in Ser, Thr, and Cys residues but also contains several positively charged residues absent in the core part of KlpA. Moreover, PhzA and its relatives lack the X-X-(S/T)P motif required for the formation of the N-terminal amidine cycle, which is strictly required for the activity of KLB 12 . Therefore, we hypothesized that the phzEACBD and similar BGCs from other Rhizobiales might encode closely related LAPs with structural and functional properties different from those of KLB or other known compounds of the family. 
Purification and characterization of a new LAP.
Reverse-phase HPLC analysis of medium after cultivation of the Rhizobium sp. Pop5 led to the identification of several fractions absorbing at 254 nm, a wavelength previously used in the purification of other azole-containing compounds (Figure S1A) 8, 13 . MALDI-TOF-MS analysis of the selected fractions showed the presence of compounds, which, based on the observed masses, appeared to be the products of the PhzA precursor peptide posttranslational modification Figure S3 ). PHZ is a 27-residue long peptide with three thiazole and five oxazole cycles in its structure. The cycles are distributed evenly across the core part of the precursor peptide with every third residue being turned into an azole ( Figure 1C ). In addition to the major fractions, several minor forms with a fewer (5-7)
number of azole cycles were detected in the cultivation medium ( Figure S1B ). Compounds with less than eight cycles lacked the C-terminal cycles, consistent with the N-to C-terminus direction of modification of the PHZ precursor peptide.
PHZ demonstrates antimicrobial activity against a variety of Rhizobiales.
When the purified phazolicin was tested against Escherichia coli BW25113 grown on rich solid medium, small growth inhibition zones were observed only when the compound was applied in The resistance of producing strains to RiPPs with antimicrobial activity often results from the efficient export of the mature compound by a specific transporter encoded in the corresponding BGC 16 . However, there are examples of BGCs containing additional genes providing selfimmunity through different mechanisms 17, 18 . Expression of a plasmid-borne copy of the phzE gene, which was annotated as an exporter pump, in S. meliloti Sm1021 conferred resistance to external PHZ and increased the MIC more than 100-fold in comparison with the strain carrying an empty vector ( Table 1) . These data confirm the role of PhzE transporter in self-immunity of the producing strain to phazolicin.
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PHZ inhibits bacterial protein translation both in vivo and in vitro.
To determine the mode of action of phazolicin we tested its activity in vivo using an E. colibased double-reporter system that allows one to identify antibiotics inducing ribosome stalling or inhibiting DNA replication 19 is an inhibitor of translation (Figure 2A , left panel). In this assay, we observed a difference in the size of PHZ-induced inhibition zones between the E. coli strain with the deleted tolC gene and the wild-type strain (Figure 2A , right panel). TolC is a major outer membrane multidrug efflux porin that is responsible for the export of various compounds from the cell including siderophores (e.g., enterobactin 20 ), macrolide antibiotics 21 , and some RiPPs (e.g., microcin J25 22 ).
In contrast to the situation observed with PHZ, the KLB-induced inhibition zones were comparable in size between the two tolCand wild-type E. coli strains, suggesting that PHZ but not KLB is subject to TolC-dependent efflux.
To further confirm that PHZ is a protein synthesis inhibitor, we tested its ability to decrease the 
PHZ obstructs the nascent peptide exit tunnel of the ribosome.
Protein synthesis inhibitors can interfere with the activity of the ribosome or any of the various other enzymes associated with protein production (translation factors, aminoacyl-tRNA synthetases, etc). Following the analogy with KLB, we proposed that PHZ acts upon the bacterial ribosome. To determine the exact mechanism of translation inhibition by PHZ we attempted to crystallize the 70S ribosome from Thermus thermophilus (Tth) in complex with PHZ, mRNA, and tRNAs, as previously done with KLB 8 , and several other translation inhibitors [23] [24] [25] [26] [27] [28] [29] [30] . Despite numerous attempts, we were not able to observe any positive electron density peaks corresponding to the ribosome-bound PHZ anywhere within the Tth 70S ribosome.
Moreover, in vitro translation inhibition experiments using E. coli (Eco) 70S or hybrid 70S (Eco 30S subunit + Tth 50S subunit) demonstrated that PHZ does not target Tth ribosome (Figure S4) .
However, the same data also suggested that PHZ does target the large ribosomal subunit of the E. coli ribosome.
Since the crystallization-based approach was unsuccessful, we switched to cryo-EM to determine the structure of PHZ bound to the sensitive Eco 70S ribosome. The obtained charge density map, characterized by the overall resolution of 2.87 Å according to the "gold-standard" Fourier shell correlation (FSC) method (Figure S5A) , revealed PHZ bound to the ribosome (Figure 3A) . The high resolution and excellent quality of the map in the PHZ binding site (Figure S5B ), allowed us not only to fit its atomic model (residues 2-23; Figure 3B ) but also to confirm the positions of seven azoles in the structure of the modified peptide proposed according to the MS-MS analysis.
While the results of tandem mass spectrometry indicate another oxazole present at the position Travin D.Y. et al.
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Similar to KLB, linear modified PHZ peptide forms a compact globule that binds in the upper part of the nascent peptide exit tunnel (NPET) of the 50S ribosomal subunit where it extensively interacts with the 23S rRNA and ribosomal proteins (Figure 3C, D; Movie S1). In comparison to antibiotics of smaller molecular weight such as ERY, which binds at the same location but only partially occludes the NPET (Figure S6A, B) , binding of both KLB and PHZ results in nearly complete obstruction of the NPET (Figure S6C, D) . A prominent feature of the ribosomebound PHZ molecule is its complex intramolecular interactions that involves both face-to-face and edge-to-face π-π stacking of Thz12, Oxz21, Thz6, and Oxz18, along with the nucleobase U2609 from the 23S rRNA ( Figure 3F; Figure S7D ). Moreover, we observed two major types of interactions between the PHZ and the nucleotides of the 23S rRNA. First, three azoles (Thz3, Oxz15, and Oxz18) are involved in π-π stacking with nucleotides A751, C2611, and U2609, respectively (Figure 3E, F Apparently, there is more space between the ribosome-bound drug and the PTC in the case of PHZ in comparison to KLB. This suggests that PHZ should, in principle, allow for a few more amino acids to be incorporated into the nascent polypeptide chain before it encounters the NPETbound PHZ molecule and translation stalls. To test this hypothesis, we performed a toe-printing (primer-extension inhibition) assay, which allows identification of drug-induced ribosome stalling on a given mRNA template with a single-nucleotide precision 32 . Because PHZ causes strong induction (stalling of the ribosomes) on Dualrep2 reporter used in our in vivo bioactivity test (Figure 2A) , we have chosen the corresponding mRNA (trpL-2Ala) as a template for our toe-printing assay. Addition of PHZ to the PURExpress cell-free transcription-translation system programmed with trpL-2Ala mRNA resulted in dose-dependent ribosome stalling at the seventh codon of mRNA (Figure 4C, lanes 4-7) while the addition of KLB induced major stalling at the third and the fifth codons (Figure 4C, lane 3) corroborating our hypothesis. Moreover, these data indicate that PHZ is an inhibitor of the elongation step during protein synthesis, as is the KLB.
Importantly, in the presence of any of the tested antibiotics, ribosome cannot rich codons 9-10, at which it stalls in the absence of any inhibitors due to the mRNA secondary structure (Figure 4C Note that owing to the large size of the ribosome, the reverse transcriptase stops at the nucleotide +16
relative to the codon located in the P-site.
Amino acid sequence of the ribosomal protein uL4 loop determines species-specificity of PHZ action.
The PHZ binding site is adjacent to the NPET constriction pointthe most narrow part of the NPET formed by the extended loops of the ribosomal proteins uL4 and uL22 (Figure 5A, B) .
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The N-and C-terminal parts of the PHZ molecule are located between the uL4 and uL22 loops ( Figure 5C ) and occupy more space in this part of the NPET than the C-terminal part of KLB ( Figure 5D) . The amino acid sequences of uL4 and uL22 proteins including their loop regions vary between distinct bacteria (Figure 5E) . Superpositioning of our Eco 70S ribosome structure with bound PHZ with the structure of Tth 70S reveals that residues His69 of the Tth protein uL4
and residue Arg90 of the Tth protein uL22 sterically clash with the PHZ molecule ( Figure 5C) rationalizing why PHZ does not bind to or act upon the Tth ribosome. Because the same residues in Eco ribosome are represented by less bulky Gly64 (uL4), we hypothesized that the differences in the uL4 loop sequence are responsible for the inability of PHZ to bind in the NPET and, hence, to inhibit the translation by Tth ribosome. To test our hypothesis, we expressed a plasmid-borne copy of the S. meliloti rplD gene encoding for the uL4 protein carrying the Tth-like G68H substitution (rplD G68H ) and showed that the loop structure of Tth uL4 confers resistance to PHZ and allows growth of otherwise sensitive strain on the medium with 10xMIC of the antibiotic (Figure 5F) . 
DISCUSSION
The newly discovered antibiotic phazolicin represents the second known example of a linear azole-containing peptide with a known mechanism of action and mode of binding to its intracellular target, the ribosome. Although the PHZ and the previously described LAP klebsazolicin both inhibit the elongation step of prokaryotic translation through the obstruction of the NPET of the large ribosomal subunit, the mode of binding of PHZ to the bacterial ribosome is significantly different from that of KLB. Unlike KLB, which does not appear to have extensive intramolecular interactions, four out of eight azole rings of PHZ form continuous π-πstacking system (Figure S5D) , which apparently improves the rigidity and stability of the antibiotic in its binding site. Moreover, PHZ contains several positively charged side chains, which provide additional anchoring on the ribosome through the electrostatic interactions with the negatively charged 23S rRNA (Figure 3E) , and which were absent in KLB. Finally, PHZ appears to be the first ribosome-targeting antibiotic with a pronounced bacterial species-specific mode of action, which is directly related to its mode of interaction with the molecular target. (Figure 5E ). However, others (e.g., T.
thermophilus) contain histidine that renders them naturally resistant to this antibiotic due to a steric hindrance with PHZ molecule. There are many ribosome-targeting antibiotics that, as PHZ (see Table 1 ), work on one group of bacteria and do not work on the others, however, this phenomenon is usually not referred to as "species-specificity of action" because it is due to the ability of a drug to get inside the bacterial cell rather than a differential activity on its target.
To our knowledge, PHZ is the first example of a bacterial ribosome-targeting inhibitor whose activity depends not only on its ability to penetrate inside the cell but also on the fine structure of its target, the 70S ribosome, regardless of its methylation. Moreover, PHZ is the second known 
MATERIALS AND METHODS
Bacterial strains and growth conditions.
The following bacterial strains were used in the present study: Rhizobium sp. Azorhizobium) were cultivated in YEB medium (per 1 L: 5 g beef extract, 5 g peptone, 5 g sucrose, 1 g yeast extract, 0.2 g MgSO4, pH 7.5) ( Table 1) . All rhizobia strains were cultivated at 28°C. Growth of all other strains was performed in LB medium (per 1 L: 5 g NaCl, 10 g tryptone, and 5 g yeast extract) at 28°C or 37°C (for E. coli strains). When necessary, antibiotics were used at concentrations of 100 μg/ml for kanamycin (for S. meliloti Sm1021), 50 μg/ml for kanamycin (for E. coli strains), 25 μg/ml for chloramphenicol, and 500 μg/ml for streptomycin.
Molecular cloning procedures.
Primers used for DNA amplification are listed in Table S1 . The rplD gene was amplified from 
High-resolution MS and ESI-MS-MS analysis
One microgram of peptides in a volume of 1-4 µL was loaded onto the Acclaim µ-Precolumn Precursors with a charge state of +1 and more than +5 were rejected and all measured precursors were dynamically excluded from triggering of a subsequent MS/MS for 20 s.
MALDI-ToF-MS and MS-MS analysis.
MALDI-MS mass spectra were recorded in a positive ion measurement mode using Ultraflextreme MALDI-ToF-ToF-MS instrument (Bruker Daltonics, Germany). The spectra were obtained in reflecto-mode with the accuracy of measuring the monoisotopic m/z ratio up to 0.1 Da. The fragmentation spectra were obtained using the Lift mode, for which the accuracy of measuring the daughter ions was within 0.2 Da. Sample aliquots were mixed on a steel target with a 30 mg/ml 2,5-dihydroxybenzoic acid in 0.5% trifluoroacetic acid and a 30% MeCN-water solution (Sigma-Aldrich).
Determination of minimal inhibitory concentrations (MICs).
Determination of MICs was performed in 96-well plates in different media for different bacterial strains ( Table 1 ) using a microdilution assay. In each row, the next well contained two times less antibiotic than the previous one. Two different concentration ranges were tested: 128 μM to 0.5 μM for the strains less susceptible to PHZ; and 8 μM to 31.25 nM for the strains more 
Testing of PHZ activity in vivo.
For the in vivo bioactivity test (Figure 2A) , the reporter strain BW25113-pDualrep2 and
BW25113ΔtolC-pDualrep2 was used as previously described 19 . Briefly, 2 µL of solutions of tested compounds were applied onto the agar plate that already contained a lawn of the reporter strain. 10 mM PHZ, KLB, erythromycin, and 20 µM levofloxacin solutions were used. After overnight incubation of the plate at 37°C, it was scanned by ChemiDoc (Bio-Rad) using "Cy3blot" settings for RFP and "Cy5-blot" for the Katushka2S protein.
In vitro translation inhibition assays.
The inhibition of firefly luciferase synthesis by PHZ ( Figure 2B ) was assessed essentially as described previously 23 To test the ability of PHZ to act upon the E. coli vs. T. thermophilus ribosomes (Figure S3) 
Toe-printing analysis.
Toe-printing analysis was carried out essentially as previously described 35 Figure 2E . Gradients were fractionated as before, 70S peaks were collected, and ribosomes were concentrated and washed with buffer C in an Amicon stirred cell filtration system using 100k cutoff filters. Ribosomes were stored in aliquots at -80˚C. Cryo-EM data analysis. Cryo-EM data processing was done using RELION 3.0 software 38 ( Figure S9 ; Table S2 ). The two datasets were processed separately until the final round of map refinement, for which the best particles from both sets were combined. Movies were motioncorrected and dose-weighted using RELION's motion correction algorithm. Contrast transfer function (CTF) parameters were estimated using CTFFind4 39 and micrographs with poor CTF fit, as determined by visual inspection, were sorted out. Particles were picked automatically with the Laplacian-of-Gaussian method and subjected to several rounds of careful 2D class-based cleaning before an initial round of 3D auto-refine. CTF refinement with per-particle defocus and beam tilt correction was performed, and particles were further sorted through 3D classification without alignment. Another round of 3D auto-refine was performed on the best 3D classes with focused refinement on the 50S subunit. This was followed by one round of Bayesian polishing 38 Travin D.Y. et al.
Cryo-electron microscopy (cryo-EM) structure determination.
Cryo
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and another round of CTF refinement, which were each followed by another round of 3D autorefine with a mask around the 50S subunit. Particles from the two sessions were then pooled for the final round of 3D auto-refine. A charge density map was calculated in Chimera 40 as previously described 41 . Post-processing was also performed in RELION to generate a Fourier shell correlation (FSC) curve. All refinement procedures were run on 2x binned particles because of the small pixel size.
Model building. Assembly #2 from the PDB entry 4YBB 42 was used as a starting ribosome model. Only the 50S subunit was subjected to real-space refinement in PHENIX 43 , because charge density corresponding to the 30S subunit was relatively poor after focused refinement on the 50S, where PHZ binds. Ions and water molecules were removed from the starting model prior to real-space refinement. The atomic model for the PHZ was built as follows: first, baton building in COOT 44 was used to trace the main chain; next, the resulting polyalanine chain was mutated to the unmodified PHZ sequence after visual search for the characteristic features in the map; next, oxazole and thiazole modifications were built in Avogadro 45 version 1.2.0 (http://avogadro.cc) based on the density. Finally, CIF restraints for the oxazole and thiazole moieties were created based on the structural data from 46 .
All figures showing atomic models were generated using the PyMol software (www.pymol.org).
USCF Chimera was used for EM density maps shown in Figs. S5 and S9.
